Voya Financial Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Voya Financial Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $260,512 - $307,755	-551 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $44,673 - $54,820	100 Added 22.17%	551 $259,000
Q4 2020 Mar 05, 2021	SELL	$478.3 - $607.98 $21,045 - $26,751	-44 Reduced 8.89%	451 $216,000
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $53,385 - $64,504	-98 Reduced 16.53%	495 $284,000
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $123,823 - $161,623	-251 Reduced 29.74%	593 $362,000
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $283,735 - $417,298	844 New	844 $399,000

1,531

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Voya Financial Advisors, Inc. with notifications on news.